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Dr V. Mohan Reddy (Stanford, Calif). This study primarily
sought to evaluate the effect of a strategy of repair on late func-
tional outcomes and exercise capacity, especially to see if the
biventricular strategy was superior to the single-ventricle or
1.5-ventricle repair strategy. Despite the limitation that only
39% of the survivors participated in the study and only 63% to
77% completed all the tests, the study provides important infer-
ences and is definitely a major contribution to the field.
The major strength in these 3 groups—namely, the biventricu-
lar, 1.5-ventricle, and single-ventricle groups—is that they are di-
agnosis–concordant and that the initial strategy of surgical repair is
based on sound principles. It also appears that forcing biventricular
repair in patients with lower z-scores reflects our obsession with
2-ventricle repairs, and perhaps this data will compel us to rethink
that strategy. Having said that, I have several questions. First, were
there enough patients in each group who completed all the tests? If
so, did you analyze them separately?
Dr Karamlou. That’s a very important question, as was the ini-
tial question, which was to determine if there is a tricuspid valve
cutpoint that can guide all of our clinical decision making. Unfor-
tunately, we were not able to determine a definitive cutpoint based
on this study. I can tell you that if you look at the data and youdiovascular Surgery c Volume 145, Number 4 1025
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-2 would give you a statistically significant difference between
a univentricular repair on one hand and a biventricular repair on
the other hand. But unfortunately, when you look at this as
a continuum, we couldn’t determine the threshold that you’re
seeking.
Dr Reddy. Thank you. The second question is: Within the bi-
ventricular group is there a cutoff of initial tricuspid valve z-score
that predicted the functional capacity and the exercise capacity?
Dr Karamlou. That’s an important question that we sought to
answer and determine if there is a cutpoint that can guide all of
our clinical decision making. Unfortunately, we were not able to
determine a definitive cutpoint based on this study. I can tell you
that if you look at the data and you segregate things, it looks
like a tricuspid valve Z-score of about minus 2 would give you
a statistically significant difference between a univentricular repair
on one hand and a biventricular repair on the other hand. But un-
fortunately, when you look at this as a continuum, we couldn’t de-
termine the threshold that you’re seeking.
Dr Reddy. Within the biventricular group did you see if pres-
ence or absence of atrial septal defect influenced functional and ex-
ercise capacity?
Dr Karamlou. Yes. Unfortunately, in this particular study we
did not have echocardiographic information that was concomitant
with all of the functional health status testing. That’s something we
hope to achieve in the future. So we didn’t with absolute certainty
know the status of the atrial septum. Now, if we knew it to be
closed based on the yearly follow-up that the data center maintains
on this cohort, we included that. But we cannot be certain that we
know the status of the atrial septum contemporaneous with our
evaluation.
Dr Reddy. That may be an important factor to see if having an
atrial septal defect would increase enough cardiac output vis-a-vis
the cavopulmonary shunt in 1.5-ventricle repair patients.
Dr Karamlou. Yes, absolutely, I agree.
DrReddy. The next question to you is: How do you explain that
the initial tricuspid valve size also correlated with peak oxygen up-
take (VO2) even in patients with a single ventricle?
DrKaramlou.Wewere perplexed initially by that relationship.
But having looked at this retrospectively as well among our other
cohorts, we saw essentially the same finding in the patients with
critical aortic stenosis and aortic valve atresia, whereby the status
of the mitral valve was influential in outcome even within patients
who were triaged to a single-ventricle repair. So exactly the con-
verse on the other side was true in that cohort.
Additionally, there are a couple of other things that one can
speculate. One is that among other types of diagnoses there is ven-
tricular interdependence and there is a ventricular interaction, so it
could be that patients along the spectrum in the univentricular
group with larger right ventricles—and therefore a large right ven-
tricular mass—have some interaction with the systemic cardiac
output, and that may influence their aerobic capacity. Second, per-
haps the tricuspid valve z-score is surrogating other unfavorable or
favorable anatomic characteristics like pulmonary arborization
that unfortunately we could not look at.
Dr Reddy. I encourage you to add a paragraph to that effect in
your discussion.
Dr Karamlou. Yes, that’s a good point.1026 The Journal of Thoracic and Cardiovascular SurDr Reddy. The next question: Peak VO2 was higher in 1.5-ven-
tricle repair compared with biventricular repair regardless of the
z-score, which suggests that tricuspid valve is not the only factor
but right ventricle end-diastolic pressures or tricuspid insuffi-
ciency may be important and a cavopulmonary shunt might offset
these factors. So my question based on this is: Should we consider
the 1.5-ventricle option for patients with pulmonary atresia with
intact ventricular septum, for all patients pulmonary atresia with
intact ventricular septum, regardless of the initial tricuspid valve
size?
Dr Karamlou.Yes, I think that question is anticipated based on
these data, and I don’t think what we’re trying to convey is that for
every anatomic subtype you should always do a 1.5-ventricle re-
pair. Again, we have to be circumspect. This was a small group
of patients—only 14 in the 1.5–ventricle-repair group—and al-
though statistically significant, the range of tricuspid valve
z-scores on either side of those lines is small. There is a physiologic
correlate to our findings in that patients with a 1.5-ventricle strat-
egy may be able to augment their cardiac output and therefore im-
prove their aerobic capacity. But again, it’s a small group of
patients and warrants further study.
Dr Reddy. Do you plan to investigate any neurodevelopment-
related outcomes in these 1.5-ventricle group patients that might
suggest that to increase the pressure in the superior vena cava
may have some implications in developmental outcomes? That
might offset recommending 1.5-ventricle repairs as opposed to
just relying on peak VO2.
Dr Karamlou. I only presented the peak VO2 data in the inter-
est of time. There are obviously comprehensive exercise variables
that we plan to look at in a separate manuscript.
In terms of the neurodevelopment-related outcomes, although
we could look at these data cross-sectionally, all would be con-
founded by not knowing what the patients started with initially.
We know from data from Children’s Hospital of Philadelphia
that these patients start out with very different neurologic pheno-
types that probably influence outcome. So although we could
look at it late, I’m not sure we could make a strong conclusion.
Dr Reddy. It might simply show if there is any effect of
increased superior vena cava pressure.
Dr Karamlou. That’s true.
Dr Reddy.My last question is: We all know that tricuspid valve
size changes as patients grow, depending upon various factors—
whether or not there is the presence of ASD, because that might
influence the amount of blood going across the tricuspid valve;
what the right ventricle end-diastolic pressure is; and what the
right ventricular function is. So if the tricuspid valve size is defi-
nitely influenced by growth, did you make any attempt to compare
the exercise capacity outcomes vis-a-vis the current tricuspid valve
z-score rather than the initial tricuspid valve z-score?
Dr Karamlou. Unfortunately we don’t have the echocardio-
graphic data contemporaneous with the exercise testing. So the
thought of the current investigation was to correlate late functional
health status with initial morphology. We don’t really know what
the tricuspid valve z-score in all patients is contemporaneous with
the functional status or the exercise testing.
Dr Reddy. I think it’s very relevant because it’s important to
know what the current size of the tricuspid valve is. And how it
has grown compared to the original size.gery c April 2013
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patients on a Fontan pathway may actually have a different trajec-
tory than biventricular repair patients. Their course isn’t static, and
so getting the echo and other ancillary data about how the patients
are doing clinically at the time of their functional status evaluation
would give us additional context in which to interpret these results.
Dr John Foker (Minneapolis, Minn). It’s important to have all
the variables when you design a study. The main issues in these pa-
tients are right ventricular and tricuspid hypoplasia. So the impor-
tant question and variable is the possibility of growth. It does not
seem logical to decide to do a single or a biventricular repair if
catch-up growth will erase the hypoplasia.
My question was going to be about growth; however, you have
already discussed that you did not analyze how well the biventric-
ular repairs grew or the difference in tricuspid valve scores with
time. My group’s previous research found that even a -4 tricuspid
valvewill grow up to normal size if you achieve total relief of right
ventricular outflow obstruction, a restrictive atrial septal defect to
encourage tricuspid valve flow yet maintain an adequate cardiac
output, and ligation of all the important coronary artery fistulas
or connections. My recommendation would be to have a growth
arm in these studies in the future.
My final point is that some children with biventricular repairs
will start to miss their pulmonary valve at about age 15 years.
They may have reduced exercise capacity until somebody screws
in a pulmonary valve. With a pulmonary valve in place these pa-
tient should have improved exercise capacity.
Dr Karamlou. Growth observation was actually in our initial
grant application and for pragmatic purposes we chose to presentThe Journal of Thoracic and Car
H
Dthe data we have. Certainly serial echocardiographic data are a crit-
ical component when studying this patient population.
Dr Charles Fraser (Houston, Tex). Would you speculate a little
bit more about the subjective findings in these patients? To me
that’s the most encouraging thing that you presented. Although
we want to make decisions using objective scientific data, if pa-
tients perceive themselves as doing well that’s a very good thing.
And it’s fascinating.
I’ll share a quick anecdote if I might. I just interviewed last
week a 77-year-old woman who was operated on by Dr Blalock
at age 5 years. She lived with a Blalock shunt for 50 years. She’s
had a wonderful life. She says ‘‘I love doctors.’’ Her quality of
life, from her perspective, was outstanding; from ours, she looked
very disabled. What do you think about that and what can we learn
from that going forward?
Dr Karamlou. It is very encouraging and important that there
is a discrepancy between the subjective and the objective mea-
sures. Such a dichotomy has been seen in other studies; patients
with congenital heart disease often believe they’re doing better
than control subjects. And it may be that there are multiple envi-
ronmental factors. For example, it may be that people pay more
attention to these patients as children. Psychosocial and emo-
tional functioning is something we don’t really understand and
it’s probably much more complex than putting somebody on
a treadmill. Or, it may be that domains like bodily pain are cali-
brated differently. If you’ve experienced multiple operations,
well, your idea of severe pain is probably different than some-
body who has not undergone surgical procedures. It is fodder
for additional studies.diovascular Surgery c Volume 145, Number 4 1027
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